|
US5807715A
(en)
|
1984-08-27 |
1998-09-15 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
EP1690934A3
(en)
|
1990-01-12 |
2008-07-30 |
Abgenix, Inc. |
Generation of xenogeneic antibodies
|
|
US5427908A
(en)
|
1990-05-01 |
1995-06-27 |
Affymax Technologies N.V. |
Recombinant library screening methods
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
EP0585287B1
(en)
|
1990-07-10 |
1999-10-13 |
Cambridge Antibody Technology Limited |
Methods for producing members of specific binding pairs
|
|
CA2124967C
(en)
|
1991-12-17 |
2008-04-08 |
Nils Lonberg |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US6818418B1
(en)
|
1998-12-10 |
2004-11-16 |
Compound Therapeutics, Inc. |
Protein scaffolds for antibody mimics and other binding proteins
|
|
AU2002213441B2
(en)
*
|
2000-10-12 |
2006-10-26 |
Genentech, Inc. |
Reduced-viscosity concentrated protein formulations
|
|
RU2004109222A
(ru)
|
2001-08-30 |
2005-10-20 |
Байорексис Фармасьютикал Корпорейшн (Us) |
Слитые белки модифицированного трансферрина
|
|
EP1620734A1
(en)
|
2003-04-25 |
2006-02-01 |
Genova Ltd. |
Secreted polypeptide species reduced cardiovascular disorders
|
|
WO2005040229A2
(en)
|
2003-10-24 |
2005-05-06 |
Avidia, Inc. |
Ldl receptor class a and egf domain monomers and multimers
|
|
US20100028995A1
(en)
|
2004-02-23 |
2010-02-04 |
Anaphore, Inc. |
Tetranectin Trimerizing Polypeptides
|
|
US20070280886A1
(en)
|
2004-09-09 |
2007-12-06 |
Bayer Healthcare Ag |
Diagnostics and Therapeutics for Diseases Associated with Adrenomedullin Receptor (Amdr)
|
|
US8278262B2
(en)
|
2004-09-21 |
2012-10-02 |
Biontech Ag |
Use of microproteins as tryptase inhibitors
|
|
DK2231860T3
(da)
|
2007-12-19 |
2011-12-05 |
Affibody Ab |
Polypeptid afledt protein A og i stand til at binde PDGF
|
|
EP3785735A1
(en)
|
2008-11-03 |
2021-03-03 |
Molecular Partners AG |
Binding proteins inhibiting the vegf-a receptor interaction
|
|
MX2012002428A
(es)
|
2009-08-27 |
2012-09-12 |
Covagen Ag |
Compuestos de union il-17 y usos medicos de los mismos.
|
|
AU2010332932B2
(en)
|
2009-12-14 |
2013-01-17 |
Navigo Proteins Gmbh |
Modified ubiquitin proteins having a specific binding activity for the extradomain B of fibronectin
|
|
RU2569745C2
(ru)
|
2010-06-08 |
2015-11-27 |
Пиерис АГ |
Мутеины липокалина слезы, связывающие альфа il-4 r
|
|
SG11201402362VA
(en)
|
2011-11-16 |
2014-06-27 |
Adrenomed Ag |
Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for reducing the risk of mortality in a patient having a chronic or acute disease or acute condition
|
|
EP2780370B1
(en)
|
2011-11-16 |
2019-09-25 |
AdrenoMed AG |
Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for use in therapy of an acute disease or acute condition of a patient for stabilizing the circulation
|
|
PL2594588T3
(pl)
|
2011-11-16 |
2014-11-28 |
Adrenomed Ag |
Przeciwciało przeciwko adrenomedulinie (ADM) lub fragment przeciwciała anty-ADM lub szkielet białkowy niestanowiący Ig anty-ADM do zastosowania w terapii
|
|
DK2780371T3
(en)
|
2011-11-16 |
2019-02-25 |
Adrenomed Ag |
ANTI-ADDRENOMEDULLIN (ADM) ANTIBODY OR ANTI-ADM ANTISTOFFRAGMENT OR ANTI-ADM NON-IG TEMPLATE FOR REGULATING LIQUID BALANCE OF A PATIENT WITH A CHRONIC OR ACUTE DISEASE
|
|
EP4086283A1
(en)
|
2011-11-16 |
2022-11-09 |
AdrenoMed AG |
Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for prevention or reduction of organ dysfunction or organ failure in a patient having a chronic or acute disease or acute condition
|
|
AU2017252212B2
(en)
|
2016-04-21 |
2023-09-07 |
4TEEN4 Pharmaceuticals GmbH |
Methods for determining DPP3 and therapeutic methods
|
|
KR20240033285A
(ko)
|
2016-12-16 |
2024-03-12 |
아드레노메드 아게 |
울혈의 중재 및 치료가 필요한 환자에서 울혈의 중재 및 치료에 사용하기 위한 항-아드레노메둘린 (ADM) 항체 또는 항-ADM 항체 단편 또는 항-ADM 비-Ig 스캐폴드
|
|
SG11202002268XA
(en)
*
|
2017-10-18 |
2020-04-29 |
Adrenomed Ag |
Therapy monitoring under treatment with an anti-adrenomedullin (adm) binder
|
|
CA3168978A1
(en)
*
|
2020-02-27 |
2021-09-02 |
Andreas Bergmann |
Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for use in therapy or prevention of shock
|